Corvus Pharmaceuticals Inc.
CRVS | NASDAQ
$12.42
-$0.14 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$12.42
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 4.58M | 8.74M | 12.62M | 13.16M | 63.46M | 16.46M |
Short-Term Investments | 52.17M | 43.22M | 14.53M | 29.14M | 5.99M | 27.8M |
Long-Term Investments | 10.99M | 12.54M | 16.12M | 21.88M | 34.27M | 37.23M |
Other Long-Term Assets | 855K | 632K | 89K | 129K | 236K | 414K |
Receivables | 374K | 216K | 63K | 633K | 539K | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 318K | 548K | 220K | 102K | 128K | 673K |
Total Current Assets | 58.21M | 54.41M | 27.96M | 43.66M | 71.31M | 45.34M |
Property-Plant & Equipment | 1.06M | 1.33M | 1.39M | 2.57M | 3.64M | 2.55M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.91M | 14.5M | 17.6M | 24.58M | 38.14M | 40.19M |
Total Assets | 71.12M | 68.91M | 45.55M | 68.24M | 109.46M | 85.53M |
Account Payables | 2.49M | 2.58M | 1.53M | 1.98M | 1.57M | 3.47M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 403K | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 5.85M | 30.02M | 929K | 1.27M | 1.97M | 180K |
Total Current Liabilities | 9.38M | 35.4M | 6.87M | 10.75M | 9.69M | 12.15M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 534K | 937K | n/a | 1.37M | 2.6M | 1.23M |
Total Liabilities | 9.91M | 36.34M | 6.87M | 12.13M | 12.29M | 13.38M |
Total Debt | 937K | 1.12M | 1.37M | 2.6M | 3.65M | 2.31M |
Book Value | 61.21M | 32.57M | 38.68M | 56.12M | 97.16M | 72.15M |
Book Value Per Share | 0.77 | 0.53 | 0.81 | 1.21 | 2.32 | 2.45 |
Common Stock | 7K | 7K | 5K | 5K | 5K | 3K |
Retained Earnings | -412.29M | -397.01M | -334.72M | -307.69M | -266.38M | -223.14M |
Comprehensive Income | -896K | -1.29M | -967K | -563K | 1.87M | 4K |
Shareholders Equity | 61.21M | 32.57M | 38.68M | 56.12M | 97.16M | 72.15M |
Total Investments | 63.17M | 55.76M | 30.65M | 51.02M | 40.26M | 65.03M |
Add to Watchlist
Select watchlists to add or remove CRVS